Ortin Global Limited (BOM:539287)

Market Cap	93.84M
Revenue (ttm)	4.42M
Net Income (ttm)	-48.27M
Shares Out	8.13M
EPS (ttm)	-5.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102
Average Volume	8,414
Open	10.73
Previous Close	n/a
Day's Range	10.73 - 11.54
52-Week Range	9.57 - 24.96
Beta	1.42
RSI	46.87
Earnings Date	May 30, 2025

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. It operates through Manufacture and Trading segments. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also...

• Industry: Pharmaceutical Preparations
• Founded: 1986
• Employees: 2
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 539287

Financial Performance

In 2023, Ortin Global's revenue was 21.12 million, a decrease of -64.93% compared to the previous year's 60.20 million. Losses were -80.41 million, 8490.8% more than in 2022.